146 related articles for article (PubMed ID: 6193602)
1. Anticoagulant and antiheparin activities of a pentosan polysulphate.
Scully MF; Weerasinghe KM; Ellis V; Djazaeri B; Kakkar VV
Thromb Res; 1983 Jul; 31(1):87-97. PubMed ID: 6193602
[TBL] [Abstract][Full Text] [Related]
2. The antiheparin effect of a heparinoid, pentosan polysulphate. Investigation of a mechanism.
Scully MF; Kakkar VV
Biochem J; 1984 Mar; 218(3):657-65. PubMed ID: 6202294
[TBL] [Abstract][Full Text] [Related]
3. Comparison between the effect of pentosan polysulphate heparin and antithrombin III injections in antithrombin III deficient patients.
Fischer AM; Dautzenberg MD; Aurousseau MH; Béguin S; Goudemand J; Hemker HC
Thromb Res; 1985 Jan; 37(2):295-307. PubMed ID: 2579452
[TBL] [Abstract][Full Text] [Related]
4. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
Ofosu FA; Blajchman MA; Modi GJ; Smith LM; Buchanan MR; Hirsh J
Br J Haematol; 1985 Aug; 60(4):695-704. PubMed ID: 2411283
[TBL] [Abstract][Full Text] [Related]
5. Effect of pentosan polysulphate administration in man on the formation of covalent complexes between heparin cofactor II and thrombin generated in plasma by contact activation.
Dol F; Sié P; Dupouy D; Boneu B
Thromb Haemost; 1986 Dec; 56(3):295-8. PubMed ID: 2436330
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin.
Ofosu FA; Sie P; Modi GJ; Fernandez F; Buchanan MR; Blajchman MA; Boneu B; Hirsh J
Biochem J; 1987 Apr; 243(2):579-88. PubMed ID: 2443128
[TBL] [Abstract][Full Text] [Related]
7. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
Scully MF; Kakkar VV
Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
[TBL] [Abstract][Full Text] [Related]
8. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
Fischer AM; Barrowcliffe TW; Thomas DP
Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
[TBL] [Abstract][Full Text] [Related]
9. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP
Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183
[TBL] [Abstract][Full Text] [Related]
10. Localization of the inhibitory site(s) of pentosan polysulphate in blood coagulation.
Wagenvoord R; Hendrix H; Soria C; Hemker HC
Thromb Haemost; 1988 Oct; 60(2):220-5. PubMed ID: 2464199
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
[TBL] [Abstract][Full Text] [Related]
12. Identification of heparin cofactor II as the principal plasma cofactor for the antithrombin activity of pentosan polysulphate (SP54).
Scully MF; Kakkar VV
Thromb Res; 1984 Oct; 36(2):187-94. PubMed ID: 6209821
[TBL] [Abstract][Full Text] [Related]
13. Pentosan polysulphate: activation of heparin cofactor II or antithrombin III according to molecular weight fractionation.
Scully MF; Ellis V; Kakkar VV
Thromb Res; 1986 Feb; 41(4):489-99. PubMed ID: 2421433
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulant activities of pentosan polysulphate (Hémoclar) due to release of hepatic triglyceride lipase (HTGL).
Barrowcliffe TW; Gray E; Merton RE; Dawes J; Jennings CA; Hubbard AR; Thomas DP
Thromb Haemost; 1986 Oct; 56(2):202-6. PubMed ID: 2433786
[TBL] [Abstract][Full Text] [Related]
15. Comparative turn-over of heparin cofactor II and antithrombin III in baboons. Influence of heparin and pentosan polysulfate administration.
Sié P; Lansen J; Lacheretz F; Verschuere B; Boneu B
Thromb Haemost; 1986 Dec; 56(3):302-7. PubMed ID: 2436331
[TBL] [Abstract][Full Text] [Related]
16. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides.
Sie P; Ofosu F; Fernandez F; Buchanan MR; Petitou M; Boneu B
Br J Haematol; 1986 Dec; 64(4):707-14. PubMed ID: 2432917
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulant activities of a pentosane polysulphate: comparison with standard heparin and a fraction of low molecular weight heparin.
Soria C; Soria J; Ryckewaert JJ; Holmer E; Caen JP
Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):455-63. PubMed ID: 6160640
[No Abstract] [Full Text] [Related]
18. Mechanism of potentiation of antithrombin III [AT-III] inhibition by sulfated xylans.
Campbell A; Nesheim ME; Doctor VM
Thromb Res; 1987 Aug; 47(3):341-52. PubMed ID: 2442830
[TBL] [Abstract][Full Text] [Related]
19. Activation of human protein C by blood coagulation factor Xa in the presence of anionic phospholipids. Enhancement by sulphated polysaccharides.
Freyssinet JM; Wiesel ML; Grunebaum L; Pereillo JM; Gauchy J; Schuhler S; Freund G; Cazenave JP
Biochem J; 1989 Jul; 261(2):341-8. PubMed ID: 2476115
[TBL] [Abstract][Full Text] [Related]
20. Activity of pentosan polysulphate and derived compounds on vascular endothelial cell proliferation and migration induced by acidic and basic FGF in vitro.
Herbert JM; Cottineau M; Driot F; Pereillo JM; Maffrand JP
Biochem Pharmacol; 1988 Nov; 37(22):4281-8. PubMed ID: 2461712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
